Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram Academic Article uri icon

Overview

MeSH Major

  • Neoadjuvant Therapy
  • Nomograms
  • Retroperitoneal Neoplasms
  • Sarcoma

abstract

  • Neoadjuvant therapy was not associated with an overall improvement in DSS in patients with primary high-grade retroperitoneal sarcoma compared with the sarcoma nomogram prediction. Histopathologic response to neoadjuvant therapy was associated with a significantly improved DSS compared with nonresponders and with the sarcoma nomogram prediction for such patients.

publication date

  • August 15, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.25271

PubMed ID

  • 20564145

Additional Document Info

start page

  • 3883

end page

  • 91

volume

  • 116

number

  • 16